// Biotech and Pharma Therapeutics
BridgeBio sells partial rights to dwarfism drug for $100M
February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin
Eisai, Biogen likely to miss early launch goal for Alzheimer’s drug Leqembi
February 7, 2024 / Eisai / Biogen / Leqembi / United States
Vertex beats own record in cystic fibrosis as next-gen treatment goes up against Trikafta
February 5, 2024 / Vertex Pharma / Cystic Fibrosis / Trikafta / FDA
Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains
February 6, 2024 / Eli Lilly / Tirzepatide / Mounjaro / Zepbound
Talkspace, Bicycle Health Partner To Support Patients with Opioid Use Disorder
February 4, 2024 / Talkspace / Bicycle Health / Opioid / Mental Health
// 4th Industrial Revolution
Healthcare stakeholders to AI-equipped devices: We don’t trust you if we don’t know what you don’t know
February 6, 2024 / Healthcare / AI / Medical Devices
AI helps turn radiology reports around 82% faster at one outpatient imaging site
February 2, 2024 / AI / Radiology / Arizona / SimonMed
Cybersecurity’s Role in the Office of the Chief Medical Officer
February 5, 2024 / Cybersecurity / Healthcare
Mayo Clinic Is Helping Develop a Tool Providers Can Use to Curb Clinical Bias
February 4, 2024 / Mayo Clinic / Telehealth
Brainomix’s AI-enabled stroke software endorsed by NICE
February 7, 2024 / AI / Brainomix / NICE / Stroke
// Business & Markets
Novo Holdings Bolsters GLP-1 Production Capacity With $16.5B Catalent Buyout
February 5, 2024 / Novo Nordisk / GLP-1 / Catalent / Metabolic Disorder
Novo Nordisk can’t make enough of its metabolic disorder drugs to satisfy the market’s insatiable appetite for them. Two multi-billion dollar business deals provide the drugmaker with additional capacity to address that growing demand in the years to come.
AstraZeneca to invest $300M in US cell therapy plant
February 7, 2024 / AstraZeneca / Cell Therapy / Drugmakers
Venture firm Scion Life Sciences launches with $310M to back new biotechs
February 7, 2024 / Venture firm / Scion Life Sciences / Startups
Lilly sales surge on obesity, diabetes drug demand
February 6, 2024 / Eli Lilly / Obesity / Diabetes / Mounjaro
Jazz Inks Potential $880M Deal with Redx to Buy KRAS Inhibitors
February 7, 2024 / Jazz Pharma / Redx Pharma / New Deal
// Legal & Regulatory
Increasing the Impact of Opioid Settlement Funds by Investing in Health IT Infrastructure
February 7, 2024 / Opioid / Settlement / Public Health
Apple beats AliveCor lawsuit over heart-rate apps for Apple Watch
February 6, 2024 / Apple / AliveCor / Lawsuit / Startup
Communities in Metro Detroit band together to sue Big Pharma over insulin prices
February 7, 2024 / Detroit / Drug Prices / Insulin / Diabetes
Roche’s subcutaneous answer to AstraZeneca PNH drugs wins world-first approval in China
February 8, 2024 / Roche / Chugai Pharma / AstraZeneca / China / Approval
Novartis’s MorphoSys Acquisition Comes With Cancer Drugs & Antitrust Questions
February 6, 2024 / Novartis / Cancer / Acquisition / MorphoSys
// Research & Development
Already rolling in diabetes and obesity, Eli Lilly touts tirzepatide’s midstage MASH win
February 6, 2024 / Eli Lilly / Mounjaro / NASH / Zepbound
Overcoming Hearing Healthcare Barriers to Realize Gene Therapy Promise
February 6, 2024 / Healthcare / Gene Therapy / Deafness
New heart treatment to help grow replacement heart valves in the body
February 6, 2024 / Heart Treatment / Med Tech
J&J Touts Positive Phase III Results for Antibody in Autoimmune Disorders
February 6, 2024 / Johnson & Johnson / Autoimmune Disorders / Clinical Trials
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
February 6, 2024 / GSK / Phase III / Antibody-drug
// Politics
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Februry 6, 2024 / Bernie Sanders / Merck / Robert Davis / Joaquin Duato / Senate
Supreme Court to weigh whether Covid misinformation is protected speech
Februry 6, 2024 / Supreme Court / Covid / Freedom of Speech
Texas Medicaid agrees to fully cover gene therapy for Afghan refugees’ infant
February 5, 2024 / Texas / Medicaid / Gene Therapy / Afghan
Pharma CEOs Will Testify Today Over Prescription Drug Prices: Here’s What To Watch For
February 8, 2024 / Drug Prices / Senate / Bernie Sanders
How Trump could weaken Medicare drug pricing negotiations
February 7, 2024 / Medicare / Trump / Drug Prices